1 / 41

Infectious Syphilis in England: Changing epidemiology and new prevention needs

Infectious Syphilis in England: Changing epidemiology and new prevention needs. Dr Kevin Fenton Consultant Epidemiologist HIV/STI Division PHLS Communicable Disease Surveillance Centre. Outline. Recent trends in syphilis in England and Wales Resurgence of syphilis in London

kalyca
Download Presentation

Infectious Syphilis in England: Changing epidemiology and new prevention needs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Infectious Syphilis in England:Changing epidemiology and new prevention needs Dr Kevin Fenton Consultant Epidemiologist HIV/STI Division PHLS Communicable Disease Surveillance Centre

  2. Outline • Recent trends in syphilis in England and Wales • Resurgence of syphilis in London • New national enhanced surveillance requirements for infectious syphilis

  3. Recent epidemiology: Rates of infectious syphilis by country. PHLS (England, Wales & Northern Ireland), DHSS&PS (Northern Ireland) and Scottish ISD(D)5 Collaborative Group (ISD, SCIEH and MSSVD)

  4. Key Rate per 100 000 population A: 0.00 - 0.15 B: 0.16 - 0.30 C: 0.31 - 0.45 D: 0.46 - 0.60 E: 0.61 - 0.75 F: 0.76+ Males Overall UK rate: 0.55 Females Overall UK rate: 0.19 A A A A A C C F B A A A B E A B B C D F C A Recent epidemiology: New diagnoses of infectious syphilis by sex, country and English region; 2000 PHLS (England, Wales & Northern Ireland), DHSS&PS (Northern Ireland) and Scottish ISD(D)5 Collaborative Group (ISD, SCIEH and MSSVD)

  5. Recent epidemiology:Laboratory reports of infectious syphilis by probable region of acquisition: males England and Wales, 1994 to 1999 PHLS (England, Wales & Northern Ireland), DHSS&PS (Northern Ireland) and Scottish ISD(D)5 Collaborative Group (ISD, SCIEH and MSSVD)

  6. The London enhanced surveillance programme for infectious syphilis

  7. London enhanced surveillance:Key aims and objectives • AIM: • To improve our understanding of the distribution and determinants of infectious syphilis in London • Objectives • To characterise the recent cluster of cases • To identify key social and sexual networks; • To investigate the relationship between HIV and syphilis

  8. London enhanced surveillance:Methodology • Health Adviser led, established 1 August 2001 • 36 GUM clinics in the London region • Diagnoses of infectious syphilis: • Primary, Secondary and Early latent • Retrospective collection from 1st April – 31st July 2001 • Prospective collection

  9. Data collection form for the London enhanced surveillance programme for syphilis

  10. London enhanced surveillance:Data analysis presented in this report • Data analysis from 1st April 2001 to 12th April 2002 • Total number or reports: 393 • Number of Males: 349 • Number of Females: 44 • Reporting clinics – 86% • At least one report from 31 clinics • None from 5 clinics

  11. Descriptive analysis of data:Broad overview of notified cases

  12. London enhanced surveillance:Total number of cases reported by year Number of cases

  13. London enhanced surveillance:Number of cases by month and orientation Number of cases

  14. St Thomas’, n=22 Heterosexual female Heterosexual male Homo/bisexual male Distribution of reported cases Mortimer Market, n=49 Royal Free, n=27 Archway, n = 16 Homerton, n=17 Royal London, n= 28 St Mary’s, n=22 John Hunter, n = 62 Victoria clinic, n=19 King’s, n=21

  15. London enhanced surveillance:Reports by gender and sexual orientation Total number of reports = 393

  16. London enhanced surveillance:Reason for clinic attendance by sexual orientation p<0.001

  17. London enhanced surveillance:Age distribution by sexual orientation p<0.001

  18. London enhanced surveillance:Country of birth by sexual orientation p<0.001

  19. London enhanced surveillance:Ethnicity by sexual orientation p<0.001

  20. London enhanced surveillance:HIV status by sexual orientation p<0.001

  21. London enhanced surveillance:Reported sexual partnerships in the last three months by sexual orientation p<0.001

  22. London enhanced surveillance:Site of likely acquisition of infection p<0.001 p<0.001

  23. London enhanced surveillance:Stage of infection by sexual orientation P=0.078

  24. London enhanced surveillance:Oral sex transmission by sexual orientation p<0.001

  25. London enhanced surveillance:Relevant social venues/ networks by sexual orientation

  26. The interaction between syphilis and HIV

  27. Syphilis in HIV positive men • 128 HIV positive homo/bisexual men • Median age 37 years cf. 31 years (HIV neg.) • No significant differences with respect to:CoB, ethnicity, reasons for attending, oral sex transmission, reported partners, • However significant differences wrt. stage of infection, where possibly infected

  28. London enhanced surveillance:Stage of Infection by HIV Status

  29. Relevant social/ sexual networks

  30. Summary of key findings • Changing epidemiology • Global increases in syphilis in London • Broadly in keeping with recent national increases • Infections in heterosexuals ongoing • Predominantly from those born outside the UK, ethnic minorities • Less likely to be HIV positive, • Oral sex not a predominant feature • Over half of infections assumed to be acquired abroad

  31. Summary II • Infections in homosexual men • Ongoing • Cluster likely to have been identified through increased ascertainment • White, older (mean 36 years), HIV positive, sex on premises bars important focus • Links with other epi-centres present but not significant

  32. New arrangements for enhanced laboratory surveillance of infectious syphilis in England and Wales

  33. LAB: Sample confirmed at local laboratory REFERENCE LAB: For confirmatory testing CDSC: Merged syphilis database GUM: Patient diagnosed with syphilis Current arrangements for laboratory surveillance • Enhanced laboratory surveillance currently undertaken via the five PHLS syphilis reference laboratories • However system is limited by its poor timeliness and lack of coverage. • Approximately 40% of all diagnoses in country referred and confirmed at these sites

  34. New syphilis reporting scheme: Objectives • The new surveillance system is being established to: • monitor levels and trends of syphilis infection • provide data on risk behaviours and transmission networks • identify groups to target for testing and screening initiatives; • determine the national and regional impact of syphilis infections.

  35. LAB: Sample confirmed at local laboratory Health professional reports case directly CDSC: Merged syphilis database GUM: Patient diagnosed with syphilis Receipt of laboratory report initiates clinicalreporting New syphilis reporting scheme: Brief system description • All laboratories in England and Wales to report new cases to CDSC. • CDSC to obtain enhanced data from GUM clinics. • CDSC will also collected data from existing enhanced surveillance.

  36. LAB: Sample confirmed at local laboratory CDSC: Merged syphilis database GUM: Patient diagnosed with syphilis New syphilis reporting scheme: Phase 1: Rapid laboratory reporting • All laboratories to report to CDSC, all confirmed cases of infectious syphilis. • A laboratory reporting form or • electronic reporting via CoSurv to collect information. • Direct lab reporting should decrease delay and allow better real-time monitoring. Fig. 1 Rapid, direct laboratory reporting

  37. GUM: Health professional reports case directly CDSC: Merged syphilis database Receipt of laboratory report initiates clinicalreporting New syphilis reporting scheme: Phase 2: Enhanced patient data collection • CDSC will collate and verify laboratory data and arrange for the collection of enhanced clinical data from GUM clinics. • This will involve direct contact with the GUM physician or health adviser. • The CDSC coordinator will enter data into a password protected satellite database, linked to the lab report. Fig. 2 Passive enhanced surveillance

  38. LAB: Sample confirmed at local laboratory GUM: Patient diagnosed with syphilis GUM: Patient diagnosed with syphilis Health professional reports case CDSC: Merged syphilis database New syphilis reporting scheme: Phase 3: Active clinical reporting • Used in high incidence areas, or in sites with outbreaks. • Methodology similar to the London enhanced system: • GUM clinics to nominate a local syphilis coordinator. • Triplicate copies of the clinical data collection form to be held locally. • For each patient seen local syphilis coordinator to return form to the CDSC Fig. 3 Active enhanced surveillance

  39. New syphilis reporting scheme: Timetable for implementation • System to go ‘live’ on 1st July 2002. • Pilots already established in Eastern Region and West Midlands • Enhanced surveillance in London to be continued for the foreseeable future. • Roll-out to other regions by end-August 2002.

  40. Summary and conclusions • Recent increases in syphilis raise cause for concern • Enhanced surveillance has played a key role in syphilis prevention and control • Need for improved surveillance to co-ordinate national response • The London enhanced surveillance programme has confirmed the feasibility and acceptability for such programmes

  41. Acknowledgements • We gratefully acknowledge the continuing collaboration of health advisors, clinicians, clinic staff, microbiologists and everyone else who contributes to STI and HIV surveillance in the UK • PHLS CDSC prepares the data in collaboration with: • Scottish Centre for Infection and Environmental Health, Information and Statistics Division Scotland, Department of Health Social Services & Public Safety in Northern Ireland, Institute of Child Health, Oxford Haemophilia Centre.

More Related